Genome plasticity of BCG and impact on vaccine efficacy
- PMID: 17372194
- PMCID: PMC1838518
- DOI: 10.1073/pnas.0700869104
Genome plasticity of BCG and impact on vaccine efficacy
Abstract
To understand the evolution, attenuation, and variable protective efficacy of bacillus Calmette-Guérin (BCG) vaccines, Mycobacterium bovis BCG Pasteur 1173P2 has been subjected to comparative genome and transcriptome analysis. The 4,374,522-bp genome contains 3,954 protein-coding genes, 58 of which are present in two copies as a result of two independent tandem duplications, DU1 and DU2. DU1 is restricted to BCG Pasteur, although four forms of DU2 exist; DU2-I is confined to early BCG vaccines, like BCG Japan, whereas DU2-III and DU2-IV occur in the late vaccines. The glycerol-3-phosphate dehydrogenase gene, glpD2, is one of only three genes common to all four DU2 variants, implying that BCG requires higher levels of this enzyme to grow on glycerol. Further amplification of the DU2 region is ongoing, even within vaccine preparations used to immunize humans. An evolutionary scheme for BCG vaccines was established by analyzing DU2 and other markers. Lesions in genes encoding sigma-factors and pleiotropic transcriptional regulators, like PhoR and Crp, were also uncovered in various BCG strains; together with gene amplification, these affect gene expression levels, immunogenicity, and, possibly, protection against tuberculosis. Furthermore, the combined findings suggest that early BCG vaccines may even be superior to the later ones that are more widely used.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2.BMC Genomics. 2022 Aug 21;23(1):609. doi: 10.1186/s12864-022-08826-9. BMC Genomics. 2022. PMID: 35987561 Free PMC article.
-
Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur.Yeast. 2000 Jun 30;17(2):111-23. doi: 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G. Yeast. 2000. PMID: 10900457 Free PMC article.
-
Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccine.BMC Genomics. 2019 Jul 8;20(1):561. doi: 10.1186/s12864-019-5909-5. BMC Genomics. 2019. PMID: 31286858 Free PMC article.
-
[Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].Przegl Epidemiol. 2011;65(4):621-8. Przegl Epidemiol. 2011. PMID: 22390050 Review. Polish.
-
Recombinant BCG as a vaccine vehicle to protect against tuberculosis.Bioeng Bugs. 2010 Mar-Apr;1(2):110-5. doi: 10.4161/bbug.1.2.10483. Epub 2009 Nov 2. Bioeng Bugs. 2010. PMID: 21326936 Free PMC article. Review.
Cited by
-
The whole genome sequence of Polish vaccine strain Mycobacterium bovis BCG Moreau.Microbiol Spectr. 2024 Jul 2;12(7):e0425923. doi: 10.1128/spectrum.04259-23. Epub 2024 May 17. Microbiol Spectr. 2024. PMID: 38757975 Free PMC article.
-
Enhancing tuberculosis vaccine development: a deconvolution neural network approach for multi-epitope prediction.Sci Rep. 2024 May 6;14(1):10375. doi: 10.1038/s41598-024-59291-1. Sci Rep. 2024. PMID: 38710737 Free PMC article.
-
Expanded Scope of Bacillus Calmette-Guerin (BCG) Vaccine Applicability in Disease Prophylaxis, Diagnostics, and Immunotherapeutics.Infect Microbes Dis. 2020 Oct 20;2(4):144-150. doi: 10.1097/IM9.0000000000000040. eCollection 2020 Dec. Infect Microbes Dis. 2020. PMID: 38630099 Free PMC article. Review.
-
The profile of genome-wide DNA methylation, transcriptome, and proteome in streptomycin-resistant Mycobacterium tuberculosis.PLoS One. 2024 Jan 29;19(1):e0297477. doi: 10.1371/journal.pone.0297477. eCollection 2024. PLoS One. 2024. PMID: 38285653 Free PMC article.
-
Impaired macrophage and memory T-cell responses to Bacillus Calmette-Guerin nonpolar lipid extract.Front Immunol. 2024 Jan 11;14:1263352. doi: 10.3389/fimmu.2023.1263352. eCollection 2023. Front Immunol. 2024. PMID: 38274831 Free PMC article.
References
-
- Calmette A. La Vaccination Préventive Contre la Tuberculose. Paris: Masson; 1927.
-
- Fine PEM, Carneiro IAM, Milstien JB, Clemens CJ. Issues Relating to the Use of BCG in Immunization Programmes. A Discussion Document. Geneva: World Health Organization; 1999.
-
- Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV. Pediatrics. 1995;96:29–35. - PubMed
-
- Fine PEM. Lancet. 1995;346:1339–1345. - PubMed
-
- Bloom BR, Fine PEM. In: Tuberculosis: Pathogenesis, Protection, and Control. Bloom BR, editor. Washington, DC: Am Soc Microbiol; 1994. pp. 531–557.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous